Market Cap (In KRW)
188.88 Billion
Revenue (In KRW)
348.64 Billion
Net Income (In KRW)
-3.17 Billion
Avg. Volume
1.43 Million
- Currency
- KRW
- Country
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4920.0-11100.0
- PE
- -
- EPS
- -
- Beta Value
- -0.029
- ISIN
- KR8840090003
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Industry
- CEO
- Mr. Young-Ho Choi
- Employee Count
- -
- Website
- https://accessbio.net
- Ipo Date
- 2013-05-30
- Details
- Access Bio, Inc. engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide. The company provides Covid-19 detection kits, which are tests for assessing the current or past presence of SARS-CoV-2.; rapid diagnostic tests, suitable for preliminary diagnosis or emergency medical screening in medical facilities with limited resources; analyzers, designed to measure different chemicals and other characteristics in biological samples; and molecular diagnostic solutions used in analyzing biological markers in the genome and proteome. It offers its products under CareStart, CareUS, CareSURE, and CareGENE brand names. The company was incorporated in 2002 and is headquartered in Somerset, New Jersey.
More Stocks
-
000426
-
LXMIATO
-
SRHHYPOLTDSree Rayalaseema Hi-Strength Hypo Limited
SRHHYPOLTD
-
2430
-
OSWALSEEDSShreeOswal Seeds and Chemicals Limited
OSWALSEEDS
-
WACLYWacoal Holdings Corp.
WACLY
-
002140
-
ELPE